4//SEC Filing
CRAIG WILLIAM S 4
Accession 0001209191-09-042997
CIK 0001333248other
Filed
Sep 1, 8:00 PM ET
Accepted
Sep 2, 4:34 PM ET
Size
6.8 KB
Accession
0001209191-09-042997
Insider Transaction Report
Form 4
Transactions
- Award
Restricted stock units
2009-08-31+15,000→ 15,000 total→ Common stock (15,000 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.
- [F2]1/2 of the shares subject to the restricted stock unit award vest and convert into shares of common stock on the earlier of (a) FDA approval of the Company's NDA for intravenous acetaminophen if such approval is obtained before December 31, 2009, and (b) immediately prior to the consummation of a change in control of the Company if such change in control occurs before December 31, 2009. Subject to the recipient's election to defer the receipt of common stock subject to the other 1/2 of the shares subject to the restricted stock unit award, such shares vest and convert into shares of common stock on the earlier of (a) the one-year anniversary of FDA approval of the Company's NDA for intravenous acetaminophen, and (b) immediately prior to the consummation of a change in control of the Company. In each case, vesting is subject to the recipient's continued status as an employee, independent director or consultant of the Company or any subsidiary on the applicable vesting date.
Documents
Issuer
CADENCE PHARMACEUTICALS INC
CIK 0001333248
Entity typeother
Related Parties
1- filerCIK 0001216988
Filing Metadata
- Form type
- 4
- Filed
- Sep 1, 8:00 PM ET
- Accepted
- Sep 2, 4:34 PM ET
- Size
- 6.8 KB